Context Therapeutics Inc. (CNTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Context Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.87x | -2.30x | -0.75x | -0.70x | -0.72x | 8.41x |
| P/B Ratio | 2.31x | 0.64x | 1.52x | 0.30x | 0.16x | -3.30x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 8.52x | 35.62x | 3.83x | 11.80x | 16.90x | 0.04x |
| Quick Ratio | 8.52x | 35.62x | 3.83x | 11.80x | 16.90x | 0.04x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.35x |
YoY = year-over-year change. Source: FMP..